Literature DB >> 3631944

Entry of five antifungal agents into the ovine lung.

P D Hoeprich, J M Merry, R Gunther, C E Franti.   

Abstract

The passage of antifungal agents into pulmonary parenchyma was studied in normal sheep prepared by cannulation of the right external jugular vein and the efferent duct of the right caudal mediastinal lymph node. Five sheep were given single, sequential, intravenous injections of flucytosine, ketoconazole, BAY n 7133, amphotericin B methyl ester, and amphotericin B. Venous blood plasma and pulmonary lymph were collected before infusion and from 5 min to 24 h postinfusion; the concentrations of the drugs were assayed by a well-agar diffusion method. All drugs appeared promptly in the pulmonary lymph and disappeared at approximately exponential rates from both liquids. The lymph/plasma ratios of the drug concentrations did not differ between flucytosine and the two azoles but were lower for both polyenes. Binding by plasma proteins did not appear to be a determinant of pulmonary entry.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3631944      PMCID: PMC174910          DOI: 10.1128/AAC.31.8.1234

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution.

Authors:  P K Lunde; A Rane; S J Yaffe; L Lund; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1970 Nov-Dec       Impact factor: 6.875

2.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

3.  Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.

Authors:  P D Hoeprich; A C Huston
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

4.  Blood to lymph transport.

Authors:  H Wayland; A Silberberg
Journal:  Microvasc Res       Date:  1978-05       Impact factor: 3.514

5.  Interaction of plasma proteins and lipoproteins with amphotericin B.

Authors:  J Brajtburg; S Elberg; J Bolard; G S Kobayashi; R A Levy; R E Ostlund; D Schlessinger; G Medoff
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

6.  Entry of four cephalosporins into the ovine lung.

Authors:  S H Cohen; P D Hoeprich; R Demling; R Gunther; J M Merry; C E Franti; D J Miner
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

7.  Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole.

Authors:  P D Hoeprich; J M Merry
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

8.  Comparative susceptibility of four kinds of pathogenic fungi to amphotericin B and amphotericin B methyl ester.

Authors:  A C Huston; P D Hoeprich
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

9.  In vitro activities of two new antifungal azoles.

Authors:  P D Hoeprich; J M Merry
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

  9 in total
  1 in total

Review 1.  Tissue penetration of antifungal agents.

Authors:  Timothy Felton; Peter F Troke; William W Hope
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.